Roche Diagnostics

• AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas

  Collaborator, Phase 2, Recruiting, 242 people, 18 Dec 2025

• NCT05025293

  Collaborator, Phase 4, Completed, 228 people, 27 Aug 2021

• NCT01817699

  Collaborator, Phase 4, Terminated, 161 people, 25 Mar 2013

Sources: clinicaltrials.gov

• Economic evaluation of NT-proBNP testing plus standard clinical assessment versus standard clinical assessment alone for the prevention of heart failure in older adults with type 2 diabetes

  N/A, 28 Sept 2026

• The Malaysian Society of Gastroenterology and Hepatology Consensus Statements on Prevention and Early Detection of Hepatocellular Carcinoma in Malaysia

  14 Aug 2026

• Social Integration, Social Support and Incident Type 2 Diabetes: Results from the Prospective Heinz Nixdorf Recall Cohort Study

  4 Aug 2026

• Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease

  25 Oct 2016

Sources: api.crossref.org

• Air pollution is associated with sex-specific longitudinal changes in astrocytic and neuroinflammatory processes linked to cognitive decline in Alzheimer's disease at-risk individuals

  Employment, Consulting or advice, Fees or honoraria, Grants or research support, Board or leadership role, 1 Oct 2026

• Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial

  Consulting or advice, Fees or honoraria, 1 Oct 2026

• Different functional connectivity gradients reflect aging and Alzheimer's disease

  Grants or research support, 1 Oct 2026

• Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers

  Consulting or advice, Board or leadership role, 1 Oct 2026

• Economic evaluation of NT-proBNP testing plus standard clinical assessment versus standard clinical assessment alone for the prevention of heart failure in older adults with type 2 diabetes

  Employment, Consulting or advice, Fees or honoraria, Grants or research support, 28 Sept 2026

• Losing Muscle or Restoring Physiology? Reframing the Incretin Therapy Sarcopenia Concern

  Fees or honoraria, 28 Sept 2026

• Long-term LDL-C lowering and treatment persistence with inclisiran: 3-year follow-up from the German Inclisiran Network

  Grants or research support, 28 Sept 2026

• Multiorgan protective therapy for CKM syndrome: the role of GLP-1-based therapies and SGLT2 inhibitors

  Grants or research support, 24 Sept 2026

• Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study

  Fees or honoraria, 22 Sept 2026

• Elimination of HPV-associated cancers: universal HPV vaccination and the role of anal screening - a meeting report

  Consulting or advice, Fees or honoraria, Grants or research support, 22 Sept 2026

• Markers of Autonomic Function and Cancer Mortality Risk in Healthy Adults

  Grants or research support, 18 Sept 2026

• A scalable workflow using digital cognitive assessment and pTau217 for MCI detection

  Consulting or advice, Fees or honoraria, Grants or research support, Board or leadership role, 17 Sept 2026

• Circulating Metabolite Signatures Associated With Amyloid Positivity, Cognitive Performance and Plasma P-tau181 Levels in Cognitively Unimpaired Older Adults

  Consulting or advice, Board or leadership role, 14 Sept 2026

• Sociodemographic and clinical characteristics of participants in blood p-tau217 studies for Alzheimer's disease: A systematic review

  Consulting or advice, Fees or honoraria, Grants or research support, 10 Sept 2026

• Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies

  Consulting or advice, Fees or honoraria, 9 Sept 2026

• Reproductive lifespan in relation to diabetes mellitus and metabolic syndrome in a nationally representative population

  Fees or honoraria, 7 Sept 2026

• Integrating frailty into decision-making for disease-modifying therapies in Alzheimer's disease: a proposed expert-opinion based approach

  Consulting or advice, Fees or honoraria, Grants or research support, 4 Sept 2026

• Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study

  Consulting or advice, Board or leadership role, 3 Sept 2026

• Incident heart failure in patients with screening-detected atrial fibrillation: a post hoc analysis of the STROKESTOP and STROKESTOP II studies

  Consulting or advice, Fees or honoraria, 2 Sept 2026

• Residual Inflammatory Risk of Heart Failure and Atherosclerotic CVD in Diabetes: Look AHEAD Ancillary Study

  Consulting or advice, Fees or honoraria, Board or leadership role, 2 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov

• The Addition of the AHA PREVENT Risk Model to NT-proBNP–Based Screening in Patients with Diabetes and Risk Factors for Heart Failure: An Exploratory Analysis of TARTAN-HF

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• Multimorbidity Phenotypes in Diabetes and Their Association with 10-Year Dementia Risk: A Latent Class Analysis in the UK Biobank

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• Multimorbidity Phenotypes in Diabetes and Their Association with All-Cause Mortality: A Latent Class Analysis in the UK Biobank

  ADA Scientific Sessions 2026 abstract, 5 Jun 2026

• Relationship between Polygenetic Risk Score of BrainAge and plasma biomarkers in the A4/LEARN studies

  AAIC 2025 abstract, 24 Dec 2025

• Relationship between Polygenetic Risk Score of BrainAge and plasma biomarkers in the A4/LEARN studies

  AAIC 2025 abstract, 23 Dec 2025

• Natriuretic Peptide Screening Predicts Survival Outcomes in Individuals with Diabetes without Known Heart Failure

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025

• Comparison of Subcutaneous, Visceral, Liver, and Muscle Fat Depots in Relation to Diabetes Risk—A Prospective Cohort Study

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025

• Cost-Effectiveness of N-Terminal Pro-brain Natriuretic Peptide (NT-proBNP) in Guiding Cardiovascular Risk Prediction and Management in Chinese Patients with Type 2 Diabetes Mellitus

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025